Form 4: Humana CFO Susan Diamond Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Humana's Chief Financial Officer, Susan Diamond, reported transactions involving company stock, including the vesting of restricted stock units and related tax liability payments.
Summary
- Susan Diamond, CFO of Humana Inc., filed a Form 4 detailing changes in her beneficial ownership of Humana stock.
- On August 1, 2024, Diamond acquired 311 shares of Humana common stock through the vesting of restricted stock units.
- Also on August 1, 2024, she disposed of 142 shares to cover tax liabilities associated with the vesting of these restricted stock units at a price of $357.325 per share.
- Following these transactions, Diamond directly owns 19,960 shares of Humana common stock and indirectly owns 2,179 shares through the Humana Retirement Savings Plan.
- She also holds options to purchase a total of 27,672 shares of Humana common stock at various exercise prices and expiration dates, as well as 2,000 restricted stock units.
- Additionally, she indirectly holds 327 phantom stock units through the Humana Retirement Equalization Plan.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment about the company's performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors for signals about management's confidence in the company's prospects.
Comparison to Industry Standards
- Tracking insider transactions is a common practice in financial analysis.
- Comparing the CFO's holdings and trading activity to those of CFOs at similar healthcare companies (e.g., UnitedHealth Group, CVS Health) can provide insights into relative valuation and sentiment.
- The vesting schedules and option grants are typical components of executive compensation packages in publicly traded companies.
Stakeholder Impact
- The filing provides transparency to shareholders regarding insider transactions.
- The transactions have a minimal direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 02/22/2021 | Incentive and Non-Qualified stock options granted to reporting person, vesting in three annual increments from 2/22/22 to 2/22/24. |
| 08/01/2021 | Incentive and Non-Qualified stock options granted to reporting person, vesting in three annual increments from 8/1/22 to 8/1/24; Restricted stock units granted to reporting person, 33% of the award is vesting on 8/1/22, 8/1/23, and 8/1/24. |
| 02/21/2022 | Incentive and Non-Qualified stock options granted to reporting person, vesting in three annual increments from 2/21/23 to 2/21/25; Restricted stock units granted to reporting person, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. |
| 02/24/2023 | Incentive and Non-Qualified stock options granted to reporting person, vesting in three annual increments from 2/24/24 to 2/24/26; Restricted stock units granted to reporting person, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. |
| 02/21/2024 | Incentive and Non-Qualified stock options granted to reporting person, vesting in three annual increments from 2/21/25 to 2/21/27. |
| 08/01/2024 | Vesting of restricted stock units and disposition of shares for tax liability. |
| 08/02/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.